Results 171 to 180 of about 113,933 (287)

First Revision of the Guidelines for the Diagnosis and Management of Remethylation Disorders

Journal of Inherited Metabolic Disease, Volume 49, Issue 4, July 2026.
ABSTRACT This guideline summarizes diagnostic and therapeutic approaches based on a systematic literature review and evidence evaluation using the GRADE methodology. Given the limited high‐quality data, expert consensus was additionally obtained through a modified Delphi process.
Giorgia Olivieri, Andrea Bordugo, Birute Burnyte, Alessandro Costetti, Maria‐Luz Couce, Luisa Diogo, Francois Feillet, D. Sean Froese, Benedetta Greco, Jean‐Louis Gueant, Luciana Hannibal, Friederike Hörster, Viktor Kožich, Giancarlo La Marca, Irini Manoli, Fanny Mochel, Lorenzo Orazi, Belén Pérez, Manuel Schiff, Bernd C. Schwahn, Ida Schwartz, Karolina M. Stepien, Jolanta Sykut‐Cegielska, Trine Tangeraas, Rolf H. Zetterström, Carlo Dionisi‐Vici, Martina Huemer   +26 more
wiley   +1 more source

Tropical sprue: a narrative review of a neglected malabsorption syndrome. [PDF]

Gut Pathog
Ortiz-Prado E, Vasconez-Gonzalez J, Villavicencio-Gomezjurado M, Salazar-Santoliva C, Prieto-Marin JG, Villarreal-Burbano K, Suárez-Sangucho IA, Bastidas AP, Puente-Villamarín E, Cadena MP, Izquierdo-Condoy JS.   +10 more
europepmc   +1 more source

Vitamin‐Responsive Disorders: From Molecular Basis to Clinical Presentation and Therapy

Journal of Inherited Metabolic Disease, Volume 49, Issue 4, July 2026.
ABSTRACT Vitamin‐dependent cofactors are essential for numerous metabolic reactions, and defects affecting their uptake, conversion, utilisation, or regeneration constitute a heterogeneous group of inherited metabolic disorders (IMDs). Although dietary vitamin intake is sufficient to sustain coenzyme synthesis in healthy individuals, it is insufficient
Cécile Acquaviva, Yann Nadjar, Manuel Schiff, Christine Vianey‐Saban, Alain Fouilhoux, Jean‐François Benoist   +5 more
wiley   +1 more source

Guidance for the assessment of the dietary intake and gastrointestinal or nutrition impact symptoms etiologic criterion of Global Leadership Initiative on Malnutrition: A modified‐Delphi study

Journal of Parenteral and Enteral Nutrition, Volume 50, Issue 5, Page 614-624, July 2026.
Abstract The GLIM malnutrition diagnostic framework includes the etiologic criterion for reduced dietary intake or assimilation (i.e., digestion or absorption). This criterion required further specification to support consistent use in clinical practice.
Renée Blaauw, Heather Keller, Christine Marie Mills, Gert Bischoff, Charlene Compher, Marian de van der Schueren, Krista Haines, Nicole Kiss, Charles Lew, Ainsley Malone, Claudia Maza Moscoso, Nancy Stoner, Rocco Barazzoni, Jack J. Bell, Madeleine Coetzee, M. Isabel T. D. Correia, Ryoji Fukushima, Elena George, M. Cristina Gonzalez, Leah Gramlich, Yen Peng Lim, Roseann Nasser, Matthias Pirlich, Jacqueline A. E. Langius, Terese Scollard, Nicolette Wierdsma, Marion Winkler, Tommy Cederholm, Gordon L. Jensen   +28 more
wiley   +1 more source

Vitamin B12 deficiency: testing and treatment. [PDF]

Aust Prescr
Bedz D, Forsyth C.
europepmc   +1 more source

Radiology in malabsorption

Clinical Radiology, 1992
openaire   +2 more sources

Sustained Treatment Success With Ustekinumab in Symptomatic Stricturing Crohn's Disease: A Retrospective Single‐Arm Observational Cohort Study

MedComm, Volume 7, Issue 7, July 2026.
Data on ustekinumab (UST) for symptomatic stricturing Crohn's disease remain scarce in China. This cohort study screened 73 patients from June 2022 to April 2024, of whom 54 were eligible included, with 81.5% achieving 52‐week treatment success. Most attained sustained clinical remission alongside improved inflammation and strictures. Nonsmoking status
Jingwen Liu, Wen Hu, Shuyan Li, Shurong Hu, Deming Jiang, Yan Chen   +5 more
wiley   +1 more source

Substrate-dependent Differences of Colonic Hydrogen Production in a Patient With Fructose Malabsorption. [PDF]

J Neurogastroenterol Motil
Kriegshäuser G.
europepmc   +1 more source

Continuous Subcutaneous Versus Intestinal Levodopa Infusion for Parkinson's Disease: A Real‐World, Monocentric, Observational Study and Critical Review

Movement Disorders Clinical Practice, Volume 13, Issue 7, Page 1662-1672, July 2026.
Abstract Background Subcutaneous foslevodopa‐foscarbidopa (SCFF) is a novel, non‐surgical dopaminergic infusion therapy for better controlling motor fluctuations in advanced Parkinson's disease (PD). However, there are scarce real‐world data on efficacy, adverse events and comparisons with other infusion strategies. Objectives Here, we aimed to provide
Johannes Hartig, Lennert Sitzmann, Doreen Hartenstein, Marion Labisch, Chi Wang Ip, Jens Volkmann, Christine Daniels   +6 more
wiley   +1 more source

Frequency and predictors of fructose malabsorption in patients with functional abdominal pain syndrome: A case-control study. [PDF]

World J Gastrointest Pathophysiol
Agarwal M, Vaithiyam V, Reddy RT, Aneesh PSR, Paliwal P, Jain SR, Dalal A, Kumar A, Puri AS, Sachdeva S.   +9 more
europepmc   +1 more source